Author: healthadmin
Scientists at Stanford University have discovered an important clue to why the brain deteriorates as we age. Their research points to a breakdown in the cell’s protein production system, a process that is thought to potentially cause widespread dysfunction associated with cognitive decline and neurodegenerative diseases such as Alzheimer’s disease. This research sciencefocused on how aging disrupts “proteostasis,” or protein homeostasis. This system helps cells build, maintain, and dispose of proteins correctly. When proteostasis fails, damaged proteins accumulate into harmful clumps that can interfere with normal brain function. Researchers say the findings provide one of the clearest explanations yet for…
Recent research published in Journal of social and personal relationships provide evidence that being ignored by a romantic partner in favor of a smartphone is associated with lower relationship quality. This behavior tends to be accompanied by decreased mindfulness within the relationship, which leads to decreased valuation of the romantic relationship. This finding suggests that remaining emotionally present may protect couples from the negative patterns associated with digital distractions. In modern times, mobile phones are deeply integrated into daily life. Smartphones keep people connected to the wider world, but their presence during face-to-face interactions can disrupt immediate communication. A common…
Editor’s note: This article will be updated after the study is published Friday afternoon. Please check back later. Nearly three years after Takeda pulled Exkivity from the EGFR exon 20 lung cancer market due to Phase 3 failures, Disal Pharma has obtained data showing its small molecule drug may have what it takes to counter Johnson & Johnson’s antibodies in the first-line setting. The Chinese company’s Zegfrowi (sumvozertinib) significantly reduced the risk of disease progression or death by 35% compared to platinum-based chemotherapy as a first-line treatment for advanced non-small cell lung patients with EGFR exon 20 insertion mutations, according…
As Chinese development assets gain attention from biopharmaceutical traders, some industry watchers want to curb the trend before the U.S. loses a major biotech capability. Amid these discussions, it was no surprise that Pfizer signed a surprising development agreement with Innovent for 12 cancer drugs. And Astellas Pharma, facing a major patent cliff, is telling investors how it plans to adapt. Even more.1. As calls for expansion of the COINS law grow, will the new rules expand China’s biotechnology licenses across the board? China’s increasing share in drug development has recently become a hot topic in the life sciences field,…
Get the health information and medications you need every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Another morning round, another double feature from STAT’s Helen Branswell. Teresa and I don’t keep track of this, but I’m pretty sure Helen keeps a record of newsletters that have more than one article. US retreats from global health leadership as Ebola outbreak spreads Trump administration officials confirmed Thursday that Americans infected with Ebola will not be brought to the United States for treatment. Instead, they will be evacuated to a yet-to-be-determined location in Europe, although there is a network of…
Chronic kidney disease has become one of the most prevalent and deadly health problems in the world, with record numbers of people estimated to have impaired kidney function. A 2025 global analysis found that the number of people living with the disease increased from 378 million in 1990 to 788 million in 2023. As the world’s population grows and ages, chronic kidney disease has entered the world’s top 10 causes of death for the first time. The study was led by researchers at NYU Langone Health, the University of Glasgow, and the Institute for Health Metrics and Evaluation (IHME) at…
Analyzing key population health trends for 2026, including outbreak preparedness and strategic policies for epidemiologists and health officials.
4basebio PLC, a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, announces the commercial launch of its high-capacity single-stranded DNA (ssDNA) product line to accelerate the development of safer and more precise gene therapies by enabling targeted gene editing, advanced cell engineering, and innovative nucleic acid-based medicines. Built on a proprietary enzyme manufacturing process, this platform provides biopharmaceuticals with highly purified, long-form, end-protected ssDNA templates designed to overcome the significant manufacturing and performance bottlenecks associated with traditional chemical synthesis in CRISPR-based gene editing, enabling large-scale, clinically viable therapies. With the growth of gene editing and the need…
A report from the AARP Public Policy Institute released Thursday found that many top-brand drugs in the United States continue to become more expensive as people age, while the same drugs often become cheaper in the country.According to the report, U.S. list prices for 25 top branded drugs have increased by an average of 81% since their launch, while prices for the same drugs have fallen by an average of 13% in 19 other high-income countries.AARP also found early signs that Medicare price negotiations may be putting pressure on some list prices. Six of the 25 drugs received a one-time,…
Children with bladder and bowel problems are waiting months or even years for specialist NHS support as overstretched incontinence services struggle to keep up with rising demand, new Freedom of Information (FOI) data has revealed. FOI responses from more than 160 NHS trusts across England point to a fragmented system, with access to care varying widely by postcode and leaving many children without timely support at key stages of their development. These conditions affect an estimated one in nine children and young people in the UK, or more than 1.5 million people. But despite the scale of the need, supply…